Health care stocks advanced Friday afternoon with the NYSE Health Care Index rising 1.6% and the Health Care Select Sector SPDR Fund (XLV) adding 1.3%.
The iShares Biotechnology ETF (IBB) climbed 1.3%.
In corporate news, Novo Nordisk (NVO) shares jumped 5.4% after Health Canada accepted for review a supplemental new drug submission for semaglutide 2.4 mg as a once weekly treatment for people with metabolic dysfunction-associated steatohepatitis.
The US Department of Justice filed a complaint in federal court alleging that three of the country's largest health insurance companies offering Medicare Advantage plans paid "hundreds of millions of dollars in kickbacks" to insurance brokers from 2016 through at least 2021 to steer beneficiaries toward their plans. The DOJ named CVS Health's (CVS) Aetna, Elevance Health (ELV) and Humana (HUM) in the case, as well as brokers eHealth (EHTH), GoHealth (GOCO) and SelectQuote. CVS shares fell 3.3%, Elevance added 0.3%, Humana rose 0.7%, eHealth fell 3.1% and GoHealth dropped 4.8%.
Adaptive Biotechnologies (ADPT) shares jumped 35%, a day after the company reported a narrower loss and higher revenue in Q1.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。